Miphic
Techstars '24Wilmington, US · 1 known investors
Miphic provides imaging-based diagnostic screening of mitochondrial function to identify drug efficacy and personalized treatment options for cancer, neurodegenerative disease, diabetes, and aging-related conditions. The platform screens up to 96 conditions simultaneously to support drug discovery, personalized medicine selection, and metabolic research.
Investors · 1
In the news
- Miphic - 2025 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2024
- Miphic - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2024